Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1376.6000 14.80 (1.09%)
NSE Jun 22, 2026 15:31 PM
Volume: 299.0K
 

logo
Rubicon Research Ltd.
13 Nov 2025
1376.60
1.09%

Outperformance across metrics; stellar start to the post-IPO phase

buy
by Motilal Oswal
Target: 780
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
 
Rubicon Research has gained 183.84% in the last 1 Year
More from Rubicon Research Ltd.
Recommended
IPO market sees a major pipeline expansion with a healthy mix of mainboard and SME issues
| 22 Jun 2026, 05:55PM
Market closes higher on broad-based buying and lower crude prices
Trendlyne Marketwatch | 22 Jun 2026, 03:52PM
Five Interesting Stocks Today - June 19, 2026
The Baseline | 19 Jun 2026